Manufacturing Depression: the placebo story
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Overview
Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Love Story: Lipid Education for Women’s Heart Health
Biomarkers of the Storm: Decoding IRI’s Signature
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?